Phase 2 Chimerism Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Immune Tolerance Induction After Liver Transplantation

Liver TransplantationEnd Stage Liver DiseaseImmune Tolerance+6 more

University of California, Los Angeles12 enrolled1 locationNCT07269041

Recruiting

Phase 1Phase 2

Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels

Myeloid Chimerism

National Heart, Lung, and Blood Institute (NHLBI)32 enrolled1 locationNCT04008368

Recruiting

Phase 2

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Graft-Versus-Host DiseasePoor Graft FunctionLow Donor T-cell Chimerism

University of Liege100 enrolled12 locationsNCT00603330